Position:Assistant to the Director of the Department of Surgical Oncology
Title:Consultant
Degree/diploma:M.D., Ph.D.
Doctoral/master's supervisor:Doctoral supervisor
Areas of focus:
Personalized, precision surgical treatments for common solid tumors, with expertise in breast, thyroid, and soft tissue sarcomas; minimally invasive breast biopsy for nodules, oncoplastic breast conservation, and axillary preservation during breast cancer treatment; breast reconstructions and innovative scarless surgeries for gynecomastia and breast tumor excisions; minimally invasive treatments for thyroid and parathyroid tumors with no visible neck scarring; delicate removal and repair of breast injections and implant devices.
Biographical sketch
Dr. ZHOU Jichun is a doctoral graduate in oncology jointly trained by Yale University and Zhejiang University under a national scholarship. He completed his postdoctoral training at Yale University and served as a visiting scholar at Addenbrooke's Hospital, University of Cambridge, and St. George's Hospital, London, UK. He is a recipient of the Zhejiang Province Outstanding Youth Science Fund, a talent cultivation target for high-level healthcare professionals in Zhejiang Province, and a recipient of the Zheng Shu Medical Elite Scholarship at Zhejiang University. Dr. Zhou primarily specializes in individualized precision diagnosis and treatment, primarily through surgery, for common solid tumors such as breast, thyroid, and skin soft tissue sarcomas. He has led multiple national and provincial medical research projects and published dozens of professional papers. As a key contributor, he has been awarded the Third Prize of the Zhejiang Province Science and Technology Progress Award.
Professional memberships
Member, Breast Cancer Committee, Chinese Research Hospital Association
Youth member, Breast Oncology Group, Oncology Branch, Chinese Medical Association
Deputy Director, Youth Committee, Breast Cancer Professional Committee, Zhejiang Anti-Cancer Association
Member, Integrated Chinese and Western Medicine Breast Cancer Committee, China Anti-Cancer Association